CVS Health Corporation (NYSE:CVS) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. CVS Gets Higher Target as Bernstein Cites Management Confidence On December 12, Bernstein raised the firm’s price target on CVS Health Corporation (NYSE:CVS) to $87 from $86 and kept a Market Perform rating after what it described as a very positive Investor Day. The firm pointed to stronger confidence in the quality and depth of the management team, along with renewed conviction in the company’s market ...